Matches in Wikidata for { <http://www.wikidata.org/entity/Q92134052> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q92134052 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92134052 description "im Mai 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92134052 description "scientific article published on 15 May 2019" @default.
- Q92134052 description "wetenschappelijk artikel" @default.
- Q92134052 description "наукова стаття, опублікована 15 травня 2019" @default.
- Q92134052 name "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 name "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 type Item @default.
- Q92134052 label "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 label "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 prefLabel "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 prefLabel "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 P1433 Q92134052-7FAF85E7-FDE9-4641-8FE7-E34CC471F685 @default.
- Q92134052 P1476 Q92134052-85883114-A2A5-4A85-81C7-44DC801AC91A @default.
- Q92134052 P2093 Q92134052-6740C26A-D38E-4554-B8A3-8E27F1DBDE16 @default.
- Q92134052 P2093 Q92134052-7B07FBCB-6832-4D38-AD3D-F5AE1176113F @default.
- Q92134052 P2093 Q92134052-A8A8446B-7933-4BB4-860C-598F7E407468 @default.
- Q92134052 P304 Q92134052-C70C917A-0321-42BA-9410-F7895AA82C26 @default.
- Q92134052 P31 Q92134052-6A73F0E6-7894-4B3B-9D94-99CF388BDE6D @default.
- Q92134052 P356 Q92134052-C2428101-F676-4642-BC30-F5E9BA34A6FD @default.
- Q92134052 P433 Q92134052-0EEA7C55-39B9-4D4C-B022-4EC35405BA91 @default.
- Q92134052 P478 Q92134052-4959F7AF-AC2F-49EC-A7D6-6FCB47F84ACA @default.
- Q92134052 P577 Q92134052-208143C5-25ED-419E-88B9-86DC75334485 @default.
- Q92134052 P698 Q92134052-063F970C-246C-41D8-8D06-374B8A71104A @default.
- Q92134052 P921 Q92134052-E8AA0111-2483-4395-AA24-C8F087B354B0 @default.
- Q92134052 P356 J.JAAD.2018.10.014 @default.
- Q92134052 P698 31103317 @default.
- Q92134052 P1433 Q15757046 @default.
- Q92134052 P1476 "Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil" @default.
- Q92134052 P2093 "Chrysalyne D Schmults" @default.
- Q92134052 P2093 "Leigh A Compton" @default.
- Q92134052 P2093 "Syril Keena T Que" @default.
- Q92134052 P304 "111-122" @default.
- Q92134052 P31 Q13442814 @default.
- Q92134052 P356 "10.1016/J.JAAD.2018.10.014" @default.
- Q92134052 P433 "1" @default.
- Q92134052 P478 "81" @default.
- Q92134052 P577 "2019-05-15T00:00:00Z" @default.
- Q92134052 P698 "31103317" @default.
- Q92134052 P921 Q238512 @default.